A One-Two Punch | GenomeWeb

A One-Two Punch

Tayyaba Hasan and her colleagues developed nanocells that "combine light-based therapy with molecules" to stop cancer cells growth by limiting their supply of oxygen, reports MIT's Technology Review. The researchers enclosed the photosensitive drug verteporfin the solid polymer nanoparticles which were then, in turn, closed up in lipid particles that also contained bevacizumab, a drug that prevent blood vessel growth. The team then tested the nanocells in mice with pancreatic tumors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.